Toxic effects of interferon administered intrathecally.
作者信息
Ruutiainen J, Panelius M, Cantell K
出版信息
Br Med J (Clin Res Ed). 1983 Mar 19;286(6369):940. doi: 10.1136/bmj.286.6369.940.
Abstract
摘要
相似文献
1
Toxic effects of interferon administered intrathecally.鞘内注射干扰素的毒性作用。
Br Med J (Clin Res Ed). 1983 Mar 19;286(6369):940. doi: 10.1136/bmj.286.6369.940.
2
Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study.鞘内注射天然人成纤维细胞干扰素可减少多发性硬化症的发作。一项多中心双盲研究的结果。
Arch Neurol. 1987 Jun;44(6):589-95. doi: 10.1001/archneur.1987.00520180013008.
3
Intrathecal interferon, indomethacin, and multiple sclerosis.鞘内注射干扰素、吲哚美辛与多发性硬化症
Lancet. 1987 Feb 7;1(8528):326-7. doi: 10.1016/s0140-6736(87)92051-4.
4
Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.鞘内注射天然人成纤维细胞干扰素对多发性硬化症病情加重影响的多中心双盲研究。
Lancet. 1986;2(8521-22):1411-3. doi: 10.1016/s0140-6736(86)92730-3.
5
Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.多发性硬化症患者脑脊液IgG的寡克隆“指纹”在鞘内注射天然β-干扰素后未发生改变。
J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1308-12. doi: 10.1136/jnnp.49.11.1308.
6
Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.鞘内注射干扰素治疗多发性硬化症。一项计划中的多中心研究。
Arch Neurol. 1983 Oct 21;40(11):683-6. doi: 10.1001/archneur.1983.04050100023008.
7
Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings.静脉注射天然β干扰素治疗慢性复发缓解型多发性硬化症：临床反应及MRI/脑脊液检查结果
J Neurol. 1988 Jan;235(3):171-3. doi: 10.1007/BF00314311.
8
Intrathecal interferon in the treatment of multiple sclerosis. Patient follow-up.鞘内注射干扰素治疗多发性硬化症。患者随访。
Arch Neurol. 1985 Sep;42(9):841-7. doi: 10.1001/archneur.1985.04060080019009.
9
Intrathecal interferon in multiple sclerosis.多发性硬化症中的鞘内注射干扰素
Arch Neurol. 1982 Oct;39(10):609-15. doi: 10.1001/archneur.1982.00510220007002.
10
Intrathecal beta-interferon in multiple sclerosis.鞘内注射β-干扰素治疗多发性硬化症
Lancet. 1988 Sep 3;2(8610):563-4. doi: 10.1016/s0140-6736(88)92676-1.
引用本文的文献
1
Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.α干扰素与转移因子治疗多发性硬化症：一项双盲、安慰剂对照试验。澳大利亚多发性硬化症研究组
J Neurol Neurosurg Psychiatry. 1989 May;52(5):566-74. doi: 10.1136/jnnp.52.5.566.
本文引用的文献
1
Intrathecal interferon in multiple sclerosis.多发性硬化症中的鞘内注射干扰素
Arch Neurol. 1982 Oct;39(10):609-15. doi: 10.1001/archneur.1982.00510220007002.
2
PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables.稳定型多发性硬化症中由结核菌素纯蛋白衍生物（PPD）、美洲商陆有丝分裂原（PWM）和植物血凝素（PHA）诱导产生的干扰素：与HLA - Dw2抗原及临床变量的关联
Ann Neurol. 1982 Mar;11(3):279-84. doi: 10.1002/ana.410110308.
3
Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
J Infect Dis. 1982 Jul;146(1):109-15. doi: 10.1093/infdis/146.1.109.
4
Partial purification of human leukocyte interferon on a large scale.人白细胞干扰素的大规模部分纯化
Methods Enzymol. 1981;78(Pt A):499-505. doi: 10.1016/0076-6879(81)78161-8.
5
Toxicity of interferon.干扰素的毒性
Br Med J (Clin Res Ed). 1981 Apr 25;282(6273):1345-8. doi: 10.1136/bmj.282.6273.1345.
Zotero 插件